Consolidated Statement Of Cash Flows

Kidswell Bio Corporation - Filing #7585110

Concept 2022-04-01 to
2022-09-30
As at
2022-09-30
As at
2022-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-42,082,000 JPY
Depreciation
466,000 JPY
Interest and dividend income
-5,000 JPY
Interest expenses
13,664,000 JPY
Subtotal
-688,189,000 JPY
Decrease (increase) in trade receivables
-188,842,000 JPY
Decrease (increase) in inventories
270,537,000 JPY
Income taxes paid
-1,210,000 JPY
Net cash provided by (used in) operating activities
-709,001,000 JPY
Increase (decrease) in trade payables
71,865,000 JPY
Other, net
167,330,000 JPY
Interest and dividends received
5,000 JPY
Interest paid
-19,607,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
-23,745,000 JPY
Purchase of investment securities
-50,000,000 JPY
Other, net
0 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
970,000,000 JPY
Repayments of long-term borrowings
-25,000,000 JPY
Net cash provided by (used in) financing activities
1,446,330,000 JPY
Other, net
1,610,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
Net increase (decrease) in cash and cash equivalents
713,584,000 JPY
Cash and cash equivalents
1,874,518,000 JPY
1,160,934,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.